[Translation] A Phase IV, Open-Label, Randomized, Prospective, Interventional, Post-Approval, Efficacy and Safety Study of Mirabegron 50 mg and 25 mg in Overactive Bladder Treatment in Chinese Subjects
主要目的:在中国受试者中评估米拉贝隆治疗 OAB 的疗效。
次要目的:在中国受试者中评估米拉贝隆治疗 OAB 的安全性;评估米拉贝隆治疗 OAB 的其他疗效变量;探索不同的米拉贝隆起始剂量
[Translation] Main objective: To evaluate the efficacy of mirabegron in the treatment of OAB in Chinese subjects.
Secondary objectives: To evaluate the safety of mirabegron for OAB in Chinese subjects; to evaluate other efficacy variables for mirabegron for OAB; to explore different starting doses of mirabegron